BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30190486)

  • 1. The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis.
    Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A
    Sci Rep; 2018 Sep; 8(1):13379. PubMed ID: 30190486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis.
    Passiglia F; Rizzo S; Rolfo C; Galvano A; Bronte E; Incorvaia L; Listi A; Barraco N; Castiglia M; Calo V; Bazan V; Russo A
    Curr Cancer Drug Targets; 2018; 18(7):697-705. PubMed ID: 29521235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
    Luo J; Shen L; Zheng D
    Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic test accuracy of droplet digital PCR for the detection of EGFR mutation (T790M) in plasma: Systematic review and meta-analysis.
    Liao Y; Chen Y; Kou X; Xiao Y; Ye J; Wu A
    Clin Chim Acta; 2020 Apr; 503():190-196. PubMed ID: 31805270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

  • 6. Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients.
    Dono M; De Luca G; Lastraioli S; Anselmi G; Dal Bello MG; Coco S; Vanni I; Grossi F; Vigani A; Genova C; Ferrarini M; Ravetti JL; Zupo S
    Mol Med; 2019 Apr; 25(1):15. PubMed ID: 31029076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
    Qiu M; Wang J; Xu Y; Ding X; Li M; Jiang F; Xu L; Yin R
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):206-12. PubMed ID: 25339418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies.
    Jensen SG; Epistolio S; Madsen CL; Kyneb MH; Riva A; Paganotti A; Barizzi J; Petersen RK; Børgesen M; Molinari F; Boldorini R; Lorenzen J; Sørensen E; Christensen UB; Høgdall E; Frattini M
    PLoS One; 2021; 16(6):e0253687. PubMed ID: 34166445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA.
    Zhang R; Chen B; Tong X; Wang Y; Wang C; Jin J; Tian P; Li W
    Cancer Manag Res; 2018; 10():1209-1218. PubMed ID: 29844700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.
    Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y
    Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer.
    Normanno N; Denis MG; Thress KS; Ratcliffe M; Reck M
    Oncotarget; 2017 Feb; 8(7):12501-12516. PubMed ID: 27980215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Fan G; Zhang K; Ding J; Li J
    Oncotarget; 2017 May; 8(20):33922-33932. PubMed ID: 28430611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.
    Yao Y; Liu J; Li L; Yuan Y; Nan K; Wu X; Zhang Z; Wu Y; Li X; Zhu J; Meng X; Wei L; Chen J; Jiang Z
    Oncotarget; 2017 Jan; 8(2):2130-2140. PubMed ID: 27791985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine circulating-tumor DNA (ctDNA) detection of acquired EGFR T790M mutation in non-small-cell lung cancer: An outcomes and total cost-of-care analysis.
    Sands J; Li Q; Hornberger J
    Lung Cancer; 2017 Aug; 110():19-25. PubMed ID: 28676213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer: A PRISMA-compliant meta-analysis and systematic review.
    Zhou S; Huang R; Cao Y
    Medicine (Baltimore); 2020 Oct; 99(40):e21965. PubMed ID: 33019389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural effusion as a substitute for tumor tissue in detecting EGFR/ALK mutations in non-small cell lung cancer: A systematic review and meta-analysis.
    Pang C; Ma H; Qin J; Wang S; Wan C; Yang T; Shen Y; Wang D
    Medicine (Baltimore); 2019 May; 98(18):e15450. PubMed ID: 31045816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis.
    Chen Z; Liu HB; Yu CH; Wang Y; Wang L; Song Y
    PLoS One; 2014; 9(9):e105940. PubMed ID: 25203004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.
    Zhang S; Chen Z; Huang C; Ding C; Li C; Chen J; Zhao J; Miao L
    Analyst; 2019 Feb; 144(5):1718-1724. PubMed ID: 30663747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Biopsy and Lung Cancer.
    Pisapia P; Malapelle U; Troncone G
    Acta Cytol; 2019; 63(6):489-496. PubMed ID: 30566947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.